Jonathan P. Piccini MD, MHS, FACC, FAHA, FHRSAssociate Professor of Medicine at Duke University Medical Center and the Duke Clinical Research Institute, Durham, North Carolina
Jonathan P. Piccini, MD, MHS, FACC, FAHA, FHRS is a clinical cardiac electrophysiologist and Associate Professor of Medicine at Duke University Medical Center and the Duke Clinical Research Institute. His focus is on the care of patients with atrial fibrillation and complex arrhythmias, with particular emphasis on catheter ablation, left atrial appendage occlusion, and lead extraction. His research interests include the conduct of clinical trials and the assessment of innovative cardiovascular therapeutics for the care of patients with heart rhythm disorders. At present, he is the Director of the Duke Center for Atrial Fibrillation and Duke Center for Arrhythmia Research and Treatment Innovation at Duke University. He has served as the PI and/or study chair for several atrial fibrillation clinical trials and registries, including RESTORE SR, ORBIT AF I & II, the Micra Leadless Pacing Post-Approval Registry, and GENETIC AF. He also serves on the Clinical Working Group of the American Heart Association’s Get With The Guidelines – Atrial fibrillation (GWTG-Afib) registry program. He is an associate editor for the American Heart Journal and serves on the editorial board of several journals, including Heart Rhythm, the European Heart Journal, JACC: Clinical Electrophysiology, Circulation: Arrhythmia & Electrophysiology and the Journal of Cardiac Electrophysiology. Dr. Piccini has more than 275 publications in the field of heart rhythm medicine.
Dr. Piccini has received research grants for clinical research from Abbott, ARCA biopharma, Boston Scientific, Gilead, Janssen Pharmaceuticals, and Phillips and serves as a consultant to Allergan, Bayer, Johnson & Johnson, Medtronic, Sanofi, and Phillips.